DealSpexis sells antibiotics programme to BasileaLatest NewsMacrocycle library secialist Spexis AG is set to sell a preclinical antibiotics programme afor CHF2m to Basilea Pharmaceutica Ltd. Read more 15 January 2024 https://european-biotechnology.com/wp-content/uploads/2024/04/Basilea_Photo__29943159780_.jpeg 288 433 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-01-15 09:28:512024-07-09 11:16:19Spexis sells antibiotics programme to Basilea